News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Clinical

Latest News

May 27th 2016

Role of Early Intervention in Preventing Progression to T2D

Major Cost Drivers in T2D Management

Updates to Treatment Guidelines: Effects on Payers

Advantages of Medications that Treat Multiple Conditions

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Latest Videos

Jenny Bogard on How Payers Can Combat Childhood Obesity

Jenny Bogard on How Payers Can Combat Childhood Obesity

Dr Alan Carter on Increasing Insulin Costs

Dr Alan Carter on Increasing Insulin Costs

Dr William Polonsky on Diabetes Patients' Treatment Satisfaction and Insulin Adherence

Dr William Polonsky on Diabetes Patients' Treatment Satisfaction and Insulin Adherence

Dr Scott Ramsey on Challenges of Determining Cost Effectiveness of Novel Cancer Treatments

Dr Scott Ramsey on Challenges of Determining Cost Effectiveness of Novel Cancer Treatments

Dr Craig Portell Highlights New and Exciting Treatments for Non-Hodgkin's Lymphoma

Dr Craig Portell Highlights New and Exciting Treatments for Non-Hodgkin's Lymphoma

Dr Edward Li Discusses the Benefit Biosimilars Can Have in Oncology

Dr Edward Li Discusses the Benefit Biosimilars Can Have in Oncology

Dr Daniel George Highlights Successes of Checkpoint Inhibitors in Prostate, Bladder Cancers

Dr Daniel George Highlights Successes of Checkpoint Inhibitors in Prostate, Bladder Cancers

The Importance of Real-World Data in Type 2 Diabetes

The Importance of Real-World Data in Type 2 Diabetes

Understanding the DUAL VII Findings in Type 2 Diabetes

Understanding the DUAL VII Findings in Type 2 Diabetes

Impact of Cardiovascular Data in Type 2 Diabetes

Impact of Cardiovascular Data in Type 2 Diabetes

More News

Considerations Regarding Statin Therapy

May 27th 2016

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

May 27th 2016

Addressing the Effect of Polypharmacy on Medication Adherence

May 27th 2016

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

May 27th 2016

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

May 27th 2016

WellCare's Initiatives To Improve Care for Members With Diabetes

May 27th 2016

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

May 27th 2016

The Influence of Lipid Guidelines on Real-World Practice Patterns

May 27th 2016

Variables Involved When Adding Medications to Treat Diabetes

May 27th 2016

How Does the Potential for Weight Gain Influence Choice of Therapies?

May 27th 2016

Comparison of Guidelines From ADA and AACE

May 27th 2016

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

May 27th 2016

BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response

BySurabhi Dangi-Garimella, PhD

May 26th 2016

Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.

"It Takes a Village" to Tackle the Diabetes Epidemic

May 26th 2016

What Is the Role of the Provider in Guiding People to Better Adherence?

May 26th 2016

Using Apps to Help Patients Manage Diabetes

May 26th 2016

How Can We Align Financing Incentives With Quality?

May 26th 2016

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

May 26th 2016

Using Guidelines to Overcome Clinical Inertia

May 26th 2016

The Pharmacist as a Member of the Managed Care Team

May 26th 2016

Navigating the Evidence: From Clinical Trial to Clinical Practice

May 26th 2016

Engaging the Community to Promote Population Health

May 26th 2016

The Patient-Centered Medical Home in Diabetes Care

May 26th 2016

How Do We Evaluate Cardiovascular Risk in Diabetes?

May 26th 2016

Overview of the Diabetes Burden

May 26th 2016

Trending on AJMC

Trump Childhood Vaccine Order: What It Means for Parents and Payers

CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care

OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs

CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD

Site of Care, TDM Still Shape AYA ALL Outcomes: Emily K. Curran, MD